论文部分内容阅读
ATLV(成人T细胞白血病病毒)是致癌的一种病毒,由于输血很可能引起近10％患者重新感染。这个资料由九州大学医学部的大河内一雄教授于二月四日在东京召开的“癌特别研究公开座谈会”上发表的。这次研究的对象多是感染率高的九州地方的患者,一般认为虽然感染,但发病者在数千人当中仅有一人。日本红十字会血液研究中心很重视上述情况,已开始准备对献血者严格查对。大河内教授从1981年12月开始在一年期间对九州大学附属医院接受输血的全部患者当中的输血前没有ATLV感染并接受输血50天以后的222名病例进行了
ATLV (adult T cell leukemia virus) is a cancer-causing virus that is likely to cause re-infection in nearly 10% of patients due to blood transfusions. This information was published by a professor Kazuo Ichinoseki of Kyushu University’s medical department at the “Open Forum on Cancer Special Research” held in Tokyo on February 4. Most of the subjects in this study were from patients in Kyushu where the infection rates were high. It is generally believed that although there is only one person who is infected, the incidence is only among thousands of people. Japanese Red Cross Blood Research Center attaches great importance to the above situation has begun to prepare for blood donors rigorous check. Professor Dahenei performed 222 cases after 50 days of blood transfusions without any ATLV infection among all the patients receiving blood transfusions at the Kyushu University Hospital since December 1981 during the one-year period